Literature DB >> 24012703

Electrochemical determination of BCR/ABL fusion gene based on in situ synthesized gold nanoparticles and cerium dioxide nanoparticles.

Shenfeng Li1, Li Wang, Yajuan Li, Xiaoying Zhu, Liang Zhong, Lingsong Lu, Wei Zhang, Bei Liu, Guoming Xie, Wenli Feng.   

Abstract

An efficient DNA electrochemical biosensor, based on the gold nanoparticles (GNPs) in situ synthesized at the surface of multiwalled carbon nanotubes (MWCNTs), cerium dioxide (CeO2) and chitosan (Chits) composite membrane, was developed for the detection of BCR/ABL fusion gene in chronic myelogenous leukemia (CML). The capture probe was attached onto the nanocomposite membrane modified glassy carbon electrode (GCE) through the conjugated structure. Owing to the synergistic effects of CeO2 nanoparticles with a strong adsorption ability and MWCNTs with a large surface area and excellent electron transfer ability, the prepared composite membrane was demonstrated an efficient electron transfer ability. The biosensor was electrochemically characterized by cyclic voltammogram (CV) and differential pulse voltammetry (DPV), and the decrease of the peak currents upon hybridization was observed using methylene blue (MB) as the electroactive indicator. Under the optimized conditions, peak currents were linear over the range from 1 × 10(-9) M to 1 × 10(-)(12) M, with a detection limit of 5 × 10(-)(13) M (based on the 3σ). And the proposed method was successfully applied for the detection of PCR real samples with satisfactory results. Furthermore, the developed DNA biosensor was demonstrated a good selectivity, a reasonable stability and a favorable reproducibility, which could be regenerated easily.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BCR/ABL fusion gene; Cerium dioxide; Electrochemical DNA biosensor; In situ synthesis; Methylene blue

Mesh:

Substances:

Year:  2013        PMID: 24012703     DOI: 10.1016/j.colsurfb.2013.07.027

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  2 in total

1.  Impedimetric gene assay for BCR/ABL transcripts in plasmids of patients with chronic myeloid leukemia.

Authors:  Karen Yasmim Pereira Dos Santos Avelino; Isaac Aarón Morales Frías; Norma Lucena-Silva; César Augusto Souza de Andrade; Maria Danielly Lima de Oliveira
Journal:  Mikrochim Acta       Date:  2018-08-16       Impact factor: 5.833

Review 2.  Advanced applications of cerium oxide based nanozymes in cancer.

Authors:  Na Feng; Ying Liu; Xianglin Dai; Yingying Wang; Qiong Guo; Qing Li
Journal:  RSC Adv       Date:  2022-01-10       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.